Small bowel adenocarcinoma
The names of the lead clinicians for the IRCI Small bowel adenocarcinoma group include:
Dr Rob McWilliams (US)
Dr Arnaud Roth (EORTC)
Dr Richard Wilson (UK)
Current active trial
Current active trial: BALLAD – A global study to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (International Rare Cancers Initiative study – IRCI 002)
